News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,987 Results
Type
Article (17425)
Company Profile (126)
Press Release (163436)
Section
Business (58116)
Career Advice (936)
Deals (9341)
Drug Delivery (34)
Drug Development (23384)
Employer Resources (70)
FDA (2322)
Job Trends (4217)
News (92057)
Policy (5771)
Tag
Academia (479)
Alliances (16182)
Alzheimer's disease (404)
Antibody-drug conjugate (ADC) (65)
Approvals (2286)
Artificial intelligence (71)
Bankruptcy (78)
Best Places to Work (2876)
Biotechnology (115)
Breast cancer (70)
Cancer (616)
Career advice (753)
CAR-T (71)
Cell therapy (202)
Clinical research (18336)
Collaboration (304)
Compensation (64)
COVID-19 (737)
C-suite (93)
Data (527)
Diabetes (48)
Diagnostics (1047)
Drug discovery (50)
Earnings (15604)
Employer resources (68)
Events (30854)
Executive appointments (266)
FDA (2518)
Funding (267)
Gene therapy (134)
GLP-1 (248)
Government (609)
Healthcare (2372)
Infectious disease (782)
Inflammatory bowel disease (60)
Interviews (136)
IPO (4080)
Job creations (1470)
Job search strategy (699)
Layoffs (143)
Legal (1177)
Lung cancer (73)
Lymphoma (45)
Manufacturing (112)
Medical device (673)
Medtech (674)
Mergers & acquisitions (5390)
Metabolic disorders (180)
Neuroscience (564)
NextGen: Class of 2025 (1439)
Non-profit (450)
Northern California (681)
Obesity (101)
Opinion (167)
Patents (49)
People (21905)
Phase I (7132)
Phase II (8742)
Phase III (4932)
Pipeline (281)
Postmarket research (306)
Preclinical (2897)
Press Release (61)
Radiopharmaceuticals (80)
Rare diseases (131)
Real estate (2430)
Regulatory (4397)
Research institute (515)
Resumes & cover letters (152)
Series A (65)
Southern California (643)
Startups (1778)
United States (5705)
Vaccines (193)
Weight loss (77)
Date
Today (17)
Last 7 days (138)
Last 30 days (710)
Last 365 days (12538)
2025 (629)
2024 (12665)
2023 (13202)
2022 (16037)
2021 (16924)
2020 (13174)
2019 (9493)
2018 (7536)
2017 (8976)
2016 (8111)
2015 (9408)
2014 (9724)
2013 (9448)
2012 (6079)
2011 (6451)
2010 (5840)
Location
Africa (323)
Asia (13351)
Australia (2654)
California (1586)
Canada (566)
China (145)
Connecticut (67)
Europe (29838)
Florida (161)
Illinois (112)
Indiana (84)
Maryland (247)
Massachusetts (1263)
Michigan (65)
Minnesota (104)
New Jersey (427)
New York (400)
North Carolina (289)
Northern California (681)
Ohio (44)
Pennsylvania (339)
South America (400)
Southern California (643)
Texas (178)
Washington State (276)
180,987 Results for "sqz biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company
STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company —a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them rather than using electricity.
February 29, 2024
·
3 min read
Business
Roche Decides Not to Exercise Solid Tumor Option with SQZ
Embattled SQZ Biotechnologies announced Tuesday that the Swiss biotech will not exercise its option for HPV 16 positive solid tumors under the SQZ-APC-HPV program.
July 25, 2023
·
2 min read
·
Connor Lynch
Business
SQZ Biotechnologies Provides Update on Collaboration with Roche
SQZ Biotechnologies Company (OTC: SQZB) (the “Company” or “SQZ”) today announced that Roche has determined that it will not exercise its option for HPV 16 positive solid tumors under the SQZ-APC-HPV program.
July 25, 2023
·
4 min read
Pharm Country
NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)
The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of SQZ Biotechnologies Company — ticker symbol SQZ — from the NYSE.
July 3, 2023
·
1 min read
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Venture capitalists
Lilly Partners With a16z on $500M VC Fund for Early-Stage Biotechs
The Biotech Ecosystem Venture Fund will combine the sourcing capabilities of venture capital firm Andreessen Horowitz (a16z) with Eli Lilly’s expertise in R&D—plus half a billion in capital from the Big Pharma.
January 10, 2025
·
1 min read
·
Annalee Armstrong
Business
SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates
SQZ Biotechnologies Company (OTC: SQZB), focused on unlocking the full potential of cell therapies, today reported third quarter 2023 financial results and recent portfolio updates.
November 8, 2023
·
6 min read
Genetown
SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting
SQZ Biotechnologies Company (OTC: SQZB), focused on unlocking the full potential of cell therapies, presented clinical data for three programs focused on the treatment of Human Papillomavirus 16 positive (HB16+) driven cancers at the Society for Immunotherapy of Cancer Annual Meeting 2023.
November 3, 2023
·
4 min read
Funding
Navigating a Biotech Exit in a Rebounding Market
With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and otherwise capitalizing on exit opportunities.
November 6, 2024
·
8 min read
·
Ana Mulero
1 of 18,099
Next
